Researchers to test faecal pill efficacy in treating obesity

By Will Chu

- Last updated on GMT

The study will involve 21 obese patients given a daily pill containing another individual's freeze-dried faecal matter. Image credit: / adrian825
The study will involve 21 obese patients given a daily pill containing another individual's freeze-dried faecal matter. Image credit: / adrian825

Related tags Bacteria Obesity Gut flora

Faecal matter from a healthy, lean person can help obese individuals lose weight by transferring intestinal bacterium via a 'stool transplant,' a study intends to show. 

Scientists believe that by freeze drying the matter and administering it in pill form, a healthy microbiome will be transferred over to the overweight subject making weight loss easier.

obesity weight
The existence of a relationship between gut microbes and preventing obesity was posed in 2013. (

Research into the effect gut microbiota has on weight and metabolism has long been documented with gut microbes identified in fermenting indigestible nutrients, producing micronutrients and reducing harmful toxins. More recently research into host-microbe interactions has explored its role in vital functions and health maintenance.

Researchers, led by Elaine Yu, an assistant professor and clinical researcher at Massachusetts General Hospital, are planning to give 21 obese patients a daily pill, administered orally, that contains a couple of grams of another individual’s freeze-dried faecal matter.

The procedure, set to begin in March this year, will track changes in subjects’ body weight from baseline to 12 weeks using a metabolic scale. Changes in insulin sensitivity and lean and fat mass will also be measured.

The study is set to run for six months and it is hoped the results will make a convincing case for microbe treatments for obesity.

Faecal pill potential

This experiment will not be the first time faecal pills have been used to transplant intestinal microbes to treat a condition. A 2014 study​ published in the Journal of the American Medical Association (JAMA)​ demonstrated faecal microbiota transplantation (FMT) was effective in treating relapsing or refractory Clostridium difficile​ infection.

Additionally, the Science​ journal reported​ in 2013 a possible cause–and-effect relationship between gut microbes and the prevention of obesity. Four sets of human twins, where one twin was a healthy weight and the other was obese, donated their microbe profile to mice. The mice who received an obese twin’s microbes gained weight, regardless of their diet.

Microflora’s obesity link

The effects of gut microflora on metabolic factors and obesity have been known as far back as 2006 when a landmark paper was published​ describing different microbial profiles in the gut of obese and lean individuals. Remarkably, obese people reverted back to the microflora of a lean person when they lost weight. 

probiotic bacteria gut health live fermented
Researchers have manipulated gut microbiota using prebiotics or probiotics to shift it towards a healthier profile. (image:

Obesity is associated with phylum-level changes in the microbiota, reduced bacterial diversity, nutrient absorption and altered representation of bacterial genes and metabolic pathways. More recently, researchers have attempted to manipulate the gut microbiota using prebiotics or probiotics to shift towards a healthier profile.

A 2008 study​ suggested obesity was linked to altered mixes and lower diversity of gut microbes. Researchers found human gut microbiome was shared among family members, but each person’s gut microbial community varied in the specific bacterial lineages present, with a comparable degree of co-variation between parent and child.

However, there was a wide array of shared microbial genes among sampled individuals, comprising an extensive, identifiable ‘core microbiome’ at the gene, rather than at the organismal lineage level.

“These results demonstrate that a diversity of organismal assemblages can nonetheless yield a core microbiome at a functional level,”​ the study said. “Deviations from this core are associated with different physiologic states (obese versus lean).”

More details about Yu’s upcoming clinical study can be found here​. 

Probiota 2016​ ​in Amsterdam on February 2-4


From zombie probiotics ​to the future of microbiome science; an EFSA exclusive to global hotspot market wraps; infants and the aged; case studies; latest research and formulations plus more ​Probiota 2016 is a knowledge store you probably shouldn’t miss.

Click here​ for more information. 

Related news

Show more

Related products

show more

Nextida: Precision where it matters

Nextida: Precision where it matters

Content provided by Rousselot | 09-May-2024 | Product Brochure

NEXTIDA™ is an innovative platform of specific collagen peptide compositions with new targeted health benefits. Built and backed by science, Nextida stands...

Optimize Nutritional Value with DuraLipo™

Optimize Nutritional Value with DuraLipo™

Content provided by INNOBIO Corporation Limited | 02-May-2024 | White Paper

INNOBIO's DuraLipo™ products encapsulates active ingredients within phospholipids, forming a genuine phospholipid bilayer structure.

HRB probiotics in the HMO era

HRB probiotics in the HMO era

Content provided by Morinaga Milk Industry Co., Ltd. | 29-Apr-2024 | White Paper

Discover the science behind human-residential bifidobacteria (HRB) probiotics and their superior benefits for infants.

Women's Health Before, During & Beyond Menopause

Women's Health Before, During & Beyond Menopause

Content provided by Akay Bioactives | 26-Apr-2024 | White Paper

Discover the science of FenuSmart®, a unique fenugreek seed extract that merges ancient wisdom with modern clinical research to support women's health...

Related suppliers

Follow us


View more